Discover
MNOV
MediciNova, Inc.
1.42
2 x 1.10
2 x 1.72
bid
ask
+
0.10
7.58%
2 @ 04:00 PM
1.42 +0.00 (0.00%)
| Ytd | 8.40% | |
| 1y | 11.81% |
1.32
day range
1.55
1.17
52 week range
1.96
| Open | 1.34 | Prev Close | 1.32 | Low | 1.32 | High | 1.55 | Mkt Cap | 69.89M |
| Vol | 412.15K | Avg Vol | 41.13K | EPS | -0.23 | P/E | N/A | Forward P/E | -0.06 |
| Beta | 0.77 | Short Ratio | 11.20 | Inst. Own | 21.30% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.35 | 200-d Avg | 1.41 | 1yr Est | 8.33 |
MNOV News
globenewswire.com
MediciNova CEO Provides Shareholder Update
LA JOLLA, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr
benzinga.com
MediciNova Receives U.S. Patent Office Notice Of Allowance Covering The Use Of Ibudilast In The Trea
Once issued, this patent is expected to expire no earlier than September 2042. The allowed claims co